Cargando…
Synergistic Effect of Cefazolin Plus Fosfomycin Against Staphylococcus aureus in vitro and in vivo in an Experimental Galleria mellonella Model
Objectives: This study investigated the synergistic in vitro and in vivo activity of cefazolin plus fosfomycin against methicillin-susceptible and methicillin-resistant S. aureus (MSSA and MRSA) to provide the basis for a potential treatment alternative. Methods: Antimicrobial susceptibility and in...
Autores principales: | Kussmann, Manuel, Obermueller, Markus, Karer, Matthias, Kriz, Richard, Chen, Rui-Yang, Hohl, Lena, Schneider, Lisa, Burgmann, Heinz, Traby, Ludwig, Vossen, Matthias G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144499/ https://www.ncbi.nlm.nih.gov/pubmed/34045971 http://dx.doi.org/10.3389/fphar.2021.685807 |
Ejemplares similares
-
Different Types of Coagulase Are Associated With 28-Day Mortality in Patients With Staphylococcus aureus Bloodstream Infections
por: Karer, Matthias, et al.
Publicado: (2020) -
Pharmacodynamics Of Linezolid-Plus-Fosfomycin Against Vancomycin-Susceptible And -Resistant Enterococci In Vitro And In Vivo Of A Galleria mellonella Larval Infection Model
por: Qi, Caifen, et al.
Publicado: (2019) -
A Longitudinal Seroprevalence Study Evaluating Infection Control and Prevention Strategies at a Large Tertiary Care Center with Low COVID-19 Incidence
por: Schubert, Lorenz, et al.
Publicado: (2021) -
Biomarkers for differentiation of coronavirus disease 2019 or extracorporeal membrane oxygenation related inflammation and bacterial/fungal infections in critically ill patients: A prospective observational study
por: Weiss-Tessbach, Matthias, et al.
Publicado: (2022) -
Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis
por: Kussmann, Manuel, et al.
Publicado: (2018)